Mergers

The spray works by activating the upper airway muscles responsible for maintaining airway patency during sleep, addressing the neurological and muscular dysfunction that underlies obstructive sleep apnea (OSA).

The trial enrolled about 2,000 participants and found that both vaccines generated strong immune responses while being well tolerated.

This expansion is set to create 100 new jobs, reinforcing the company’s commitment to meeting the growing demand for advanced pharmaceutical components.

This partnership aims to develop innovative siRNA-based treatments targeting neuroscience, immunology, and oncology—areas AbbVie considers strategic priorities.

Originally set to expire on May 12, 2025, the tender offer is now extended to the end of the day on May 28, 2025, U.S. Eastern Daylight Time, according to a recent filing and announcements from the acquirer group.

Under the agreement, Alchemab will manage the initial clinical development through early Phase I trials, after which Lilly will take over later-stage development, regulatory approvals, and global commercialization.

Codix Bio is expected to reduce stockouts, lower testing costs, and improve healthcare outcomes, especially in rural and underserved communities, by producing rapid diagnostic kits locally.

The focus was on digital health, artificial intelligence, prevention, personalized and precision medicine, and longevity, marking a significant milestone in Abu Dhabi’s mission to advance health and well-being for all.

KKR already holds a 17% stake in Biotage through its life sciences platform, Gamma Biosciences, and would gain full control if the deal proceeds.